head and neck cancer
FDA Approves Neoadjuvant and Adjuvant Keytruda for Resectable, Locally Advanced Head and Neck SCC
This is the first approval for HNSCC in six years and the first overall perioperative approval for locally advanced ...
JUNE 13, 2025
FDA Approves Opdivo Qvantig for Subcutaneous Injection
The FDA approved nivolumab plus hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb) for subcutaneous ...
DECEMBER 30, 2024
Head and Neck Cancer Care Comes at High Cost
Patients with head and neck cancer have elevated treatment expenses for at least five years after diagnosis, ...
JANUARY 13, 2023
Systemic Therapy AEs Yield Big Health Care Costs for Patients With Head & Neck Cancers
Adverse events associated with systemic therapies prescribed for patients with advanced head and neck cancers may ...
MARCH 2, 2020
FDA Approves Keytruda for Metastatic Head & Neck Cancers
The FDA approved pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with metastatic or ...
JUNE 11, 2019
Investigational Immunotherapy Looks Positive for HPV-Related Epithelial Cancers
In this phase 1 study, eight patients with metastatic HPV-16 cancers received a single infusion of KITE-439. In six ...
JULY 13, 2018
Weekly Cisplatin in Nasopharyngeal, Head & Neck Ca Questioned
In one phase 3 trial conducted in nasopharyngeal cancer and another conducted in head and neck cancer, there was no ...
SEPTEMBER 28, 2017
Nivolumab Improves Survival in Refractory HNSCC
Copenhagen, Denmark—Patients with platinum-refractory, recurrent head and neck squamous cell carcinoma ...
DECEMBER 23, 2016
Opdivo Approved to Treat Head and Neck Cancer
The drug was approved to treat patients with recurrent or metastatic squamous cell carcinoma of the head and neck ...
NOVEMBER 15, 2016
New Paradigm Proposed for Nasopharyngeal Cancer Rx
Chicago—Results from a Phase III trial in China support gemcitabine plus cisplatin as standard first-line ...
AUGUST 9, 2016
Pembrolizumab Approved for Head and Neck Cancer
The therapy was approved for the treatment of patients with recurrent or metastatic head and neck squamous cell ...
AUGUST 9, 2016
Image-Guided Surgery Promising for Managing HNC
Invisible near-infrared fluorescence-guided optical imaging has potential to help surgeons visualize head and neck ...
JUNE 23, 2016
